Publication / Marina Golovnitskaya, Yauheni Budchanka
Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Belarus specifically targeted at Life Sciences companies. The government has banned export of some medical goods until at least 1 June: respirators, chemical protection suits, bandages, cotton wool, gauze, medical gloves and masks, etc. The Ministry of […]
Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Estonia specifically targeted at Life Sciences companies. A draft law is currently pending in the Estonian parliament which foresees many changes to the law due to the Covid-19 crisis. Among others, the Medicinal Products Act is […]
Publication / Eva Berlaus, Private: Gunvaldis Leitens
COVID-19 as force maejure aspect in contractual relations. Read more (in Latvian) here.
The global spread of SARS-CoV-2 is disrupting regular supply chains and has sharply increased demand for personal protective equipment. WHO reported on 3 March 2020 that since the start of the outbreak, prices of personal protective equipment had surged. The prices of surgical masks had increased six times, the prices of N95 respirators three times […]
On 30 January 2020 a global coronavirus outbreak announced by the World Health Organisation as a public health emergency caused delays in shipments from China, as well as failures in the finance, tourism, logistics and production spheres. We offer a brief overview of the most common legal issues arising in the supply sphere. Among the main examples […]